Table 6 Clinical performance of the Vibrant GPP array with archived clinical specimens
Vibrant GPP panel | No: positive samples tested | No: negative samples tested | Sensitivity % (95% CI) | Specificity % (95% CI) | PPV % (95% CI) | NPV % (95% CI) |
|---|---|---|---|---|---|---|
Vibrio parahaemolyticus | 3 | 1055 | 100 (29.2–100) | 100 (99.6–100) | 100 (29.2–100) | 100 (99.6–100) |
Vibrio vulnificus | 3 | 1055 | 100 (29.2–100) | 100 (99.6–100) | 100 (29.2–100) | 100 (99.6–100) |
Cryptosporodium spp. | 1 | 1055 | 100 (2.5–100) | 100 (99.6–100) | 100 (2.5–100) | 100 (99.6–100) |
Microsporidium spp. | 2 | 1055 | 100 (15.8–100) | 100 (99.6–100) | 100 (15.8–100) | 100 (99.6–100) |